Robert Schultz
Corporate Officer/Principal bei SATSUMA PHARMACEUTICALS, INC.
Profil
Robert Schultz is currently the Vice President & Head-CMC at Satsuma Pharmaceuticals, Inc. Prior to this, he worked at Pearl Therapeutics, Inc. as the Senior Director-Product Development from 2012 to 2017.
He also worked as a Principal at Muro Corp., KOS*USA, Inc., and GlaxoSmithKline (New Jersey).
Mr. Schultz completed his undergraduate degree at Dartmouth College.
Aktive Positionen von Robert Schultz
| Unternehmen | Position | Beginn |
|---|---|---|
| SATSUMA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.07.2017 |
Ehemalige bekannte Positionen von Robert Schultz
| Unternehmen | Position | Ende |
|---|---|---|
Pearl Therapeutics, Inc.
 Pearl Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pearl Therapeutics, Inc. develops therapies for the treatment of chronic respiratory diseases. It offers respiratory product development, high quality therapies for COPD, Asthma and treatment and prevention of chronic respiratory diseases and asthma. The company was founded in 2006 by Sarvajna Dwivedi and is headquartered in Redwood City, CA. | Corporate Officer/Principal | 01.07.2017 |
| GlaxoSmithKline (New Jersey) | Corporate Officer/Principal | - |
KOS*USA, Inc.
 KOS*USA, Inc. Apparel/FootwearConsumer Non-Durables KOS*USA, Inc. manufactures and distributes fitness apparel. It supplies tops, bodysuit, bottoms, and prints to gyms, exclusive spas, specialty stores, and boutiques. The company was founded in 1990 and is headquartered in Los Angeles, CA. | Corporate Officer/Principal | - |
| MURO CORPORATION | Corporate Officer/Principal | - |
Ausbildung von Robert Schultz
| Dartmouth College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MURO CORPORATION | Producer Manufacturing |
| Private Unternehmen | 4 |
|---|---|
Pearl Therapeutics, Inc.
Pearl Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pearl Therapeutics, Inc. develops therapies for the treatment of chronic respiratory diseases. It offers respiratory product development, high quality therapies for COPD, Asthma and treatment and prevention of chronic respiratory diseases and asthma. The company was founded in 2006 by Sarvajna Dwivedi and is headquartered in Redwood City, CA. | Health Technology |
KOS*USA, Inc.
KOS*USA, Inc. Apparel/FootwearConsumer Non-Durables KOS*USA, Inc. manufactures and distributes fitness apparel. It supplies tops, bodysuit, bottoms, and prints to gyms, exclusive spas, specialty stores, and boutiques. The company was founded in 1990 and is headquartered in Los Angeles, CA. | Consumer Non-Durables |
| GlaxoSmithKline (New Jersey) | |
Satsuma Pharmaceuticals, Inc.
 Satsuma Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It develops novel therapeutic products for the acute treatment of migraines. Its product candidate, STS101, is a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, or DHE, which is designed to be self-administered with a proprietary pre-filled, single-use, nasal delivery device. The company was founded by John Kollins on June 21, 2016 and is headquartered in Durham, NC. | Health Technology |
